Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Regulators of G protein signaling & drugs of abuse.

Traynor JR, Neubig RR.

Mol Interv. 2005 Feb;5(1):30-41. Review.

PMID:
15734717
2.

Regulator of G protein-signaling proteins and addictive drugs.

Traynor J.

Ann N Y Acad Sci. 2010 Feb;1187:341-52. doi: 10.1111/j.1749-6632.2009.05150.x. Review.

3.
4.

In situ hybridization analysis of RGS mRNA regulation and behavioral phenotyping of RGS mutant mice.

Gold SJ, Zachariou V.

Methods Enzymol. 2004;389:205-29. Review.

PMID:
15313568
5.

Psychostimulants, madness, memory... and RGS proteins?

Burchett SA.

Neuromolecular Med. 2005;7(1-2):101-27. Review.

PMID:
16052041
6.

Multi-tasking RGS proteins in the heart: the next therapeutic target?

Riddle EL, Schwartzman RA, Bond M, Insel PA.

Circ Res. 2005 Mar 4;96(4):401-11. Review.

7.

Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.

Garzón J, Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P.

Psychopharmacology (Berl). 2005 Jun;180(1):1-11. Epub 2005 Apr 14. Review.

PMID:
15830230
8.
9.

Regulators of G protein signaling: potential drug targets for controlling cardiovascular and immune function.

Cho H, Harrison K, Kehrl JH.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Jun;4(2):107-18. Review.

PMID:
15180451
10.
11.

μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.

Traynor J.

Drug Alcohol Depend. 2012 Mar 1;121(3):173-80. doi: 10.1016/j.drugalcdep.2011.10.027. Epub 2011 Nov 29. Review.

12.

[The structure, classification and function of RGS proteins].

Du YS, Huang BR.

Sheng Li Ke Xue Jin Zhan. 2005 Jul;36(3):215-9. Review. Chinese.

PMID:
16270819
13.

The pharmacology of mood-altering drugs of abuse.

Carr LA.

Prim Care. 1993 Mar;20(1):19-31. Review.

PMID:
8464940
14.

Regulator of G-protein signaling (RGS) proteins in cancer biology.

Hurst JH, Hooks SB.

Biochem Pharmacol. 2009 Nov 15;78(10):1289-97. doi: 10.1016/j.bcp.2009.06.028. Epub 2009 Jun 25. Review.

PMID:
19559677
15.

Drugs of abuse and immediate-early genes in the forebrain.

Harlan RE, Garcia MM.

Mol Neurobiol. 1998 Jun;16(3):221-67. Review.

PMID:
9626665
16.

Analysis of RGS protein palmitoylation.

Bernstein LS, Linder ME, Hepler JR.

Methods Mol Biol. 2004;237:195-204. Review.

PMID:
14501051
17.

Adolescent abuse of other drugs.

Greene JP, Ahrendt D, Stafford EM.

Adolesc Med Clin. 2006 Jun;17(2):283-318. Review.

PMID:
16814695
18.

Regulators of G protein signaling in neuropsychiatric disorders.

Terzi D, Stergiou E, King SL, Zachariou V.

Prog Mol Biol Transl Sci. 2009;86:299-333. doi: 10.1016/S1877-1173(09)86010-9. Epub 2009 Oct 7. Review.

PMID:
20374720
19.

RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins.

Abramow-Newerly M, Roy AA, Nunn C, Chidiac P.

Cell Signal. 2006 May;18(5):579-91. Epub 2005 Oct 13. Review.

PMID:
16226429
20.

Regulator of G protein signaling 5: a new player in vascular remodeling.

Manzur M, Ganss R.

Trends Cardiovasc Med. 2009 Jan;19(1):26-30. doi: 10.1016/j.tcm.2009.04.002. Review.

PMID:
19467451

Supplemental Content

Support Center